India M&As Overtook PE Activity In 2022, Deal Momentum To Continue In 2023

Biocon-Viatris Deal Largest

 
• By Vibha Ravi
  
India
Indian Pharma's M&A Activity Expected To Continue In 2023 • Source: Shutterstock
In Vivo Podcast

Candid conversations with C-suite leaders.

Keep up with strategy, innovation and evolving trends across life science industries.

SpotifyApple PodcastsWebsite

More from Global Vision

More from In Vivo